Asian Brachytherapy Seeds Market Research Report
- Report Code: BR 1004
- Publish Date: Upcoming
The Asian Brachytherapy Seeds Market, mainly driven by rapidly changing cancer treatment technology and Growing number of cancer patients, was pegged at $40 million in 2013 and expected to be $48.3 million by 2018, growing at a CAGR of 3.9%.
The report “Brachytherapy Seeds Market forecast, 2012-2018 “analyzes the market by segments such as Cesium-131, Iodine-125, Palladium-103, Iridium-192, and Other Seed Market. With a Market Value of $16.6 million and $11.3 million, Iodine-125 and Iridium-192 segments have been contributing 41.5% and 28.3% in terms of total Internal Beam Radiotherapy Devices Market.
In Asia (India, China, Japan) the rising rates of Cancer population have been driving the Market growth. The Market growth is significantly higher in North America because it is always inclined to the newer techniques while comparatively slow-moving markets such as Europe and Japan are maturing with both old and new technologies.
Currently, seed market is dominating the Internal Beam Radiotherapy market. Internal Beam Radiotherapy market holds a minor share in the entire radiotherapy market and it is further shrinking due to non-supportive government reimbursement policy in the U.S. market. Beyond the U.S. market, Europe and BRIC nations are the only potential markets to sustain this therapeutic procedure.
Prostate cancer is the model cancer for Brachytherapy. Other than skin cancer, prostate cancer is the most common cancer in American men. In 2011, there were an estimated 2,707,821 men living with prostate cancer in the United States. According to The American Cancer Society, in 2014, there will be 233,000 new cases of prostate cancer diagnosed and about 29,480 men will die of prostate cancer.
Prevalence of Cancer worldwide is around 7.4 million (53%) in males and 6.7 million (47%) in females, giving a male: female ratio of 10:9. In 2012, there were an estimated 14.1 million new cases of cancer in the world. In 2014, there will be an estimated 1,665,540 new cancer cases diagnosed and 585,720 cancer deaths in the US. Cancer remains the second most common cause of death in the US, accounting for nearly 1 of every 4 deaths.
The report also provides an extensive competitive landscaping of companies operating in Brachytherapy Seeds Market. The main companies operating in Brachytherapy Seeds Market and extensively covered in this report are Elekta AB, Theragenics corp., C.R. Bard, Eckert & Ziegler BEBIG SA.
Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.
Customization Options:
With Market data, you can also customize MMM assessments that meet your Company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of Brachytherapy Seeds products (Segment wise)
- Product Matrix which gives a detailed comparison of Brachytherapy Seeds product portfolio of each company mapped at country and sub segment level
- End-user Adoption rate analysis of the Brachytherapy Seeds products (Segment wise and Country wise)
- Comprehensive coverage of Brachytherapy Seeds Product approvals, Pipeline products and Product recalls
Epidemiology Data
- Country specific Prevalence of Prostate Cancer, Gynecological Cancer, Breast Cancer, Cervical Cancer, Penile Cancer, Lung Cancer, Head and Neck and Esophagus Cancer.
- Country specific Patient pool of Prostate Cancer, Gynecological Cancer, Breast Cancer, Cervical Cancer, Penile Cancer, Lung Cancer, Head and Neck and Esophagus Cancer.
- Disease progression (Pattern analysis)
Procedure Volume Data
- Number of Prostate Cancer, Gynecology, Breast, cervical, and Head and Neck Cancers Surgeries performed annually in each Country tracked till sub-segment level.
Surgeons/Physicians Perception Analysis
- Fast turn-around analysis of Surgeons response to market events and trends
- Surgeons opinion about products from different companies
- Surgeons qualitative inputs on epidemiology data
Brand/ Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
Pricing Trends
- Cost Analysis of Brachytherapy Seeds in Various Countries.
- Prostate Cancer, Gynecology, Breast, cervical, and Head and Neck Cancers procedural investment in major countries.
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Internal Beam Radiotherapy/Brachytherapy Market The North American Internal Beam Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $241.7 million in 2013 and expected to be $252.6 million by 2018, growing at a CAGR of 0.9%. The Internal Beam Radiotherapy Market analyzes the market of devices by 3 segments such as Internal Beam Radiotherapy/Brachytherapy are Brachytherapy Seeds, Applicators & Afterloaders and Electronic Brachytherapy.The prominent players in the Radiotherapy Devices Market globally areElekta AB, Theragenics corp., C.R. Bard, Eckert & Ziegler BEBIG SA. |
Upcoming |
|
|
European Internal Beam Radiotherapy/Brachytherapy Market The European Internal Beam Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $123.5 million in 2013 and expected to be $141.1 million by 2018, growing at a CAGR of 2.5%. The Internal Beam Radiotherapy Market analyzes the market of devices by 3 segments such as Brachytherapy Seeds, Applicators & Afterloaders and Electronic Brachytherapy.The prominent players in the Radiotherapy Devices Market globally areElekta AB, Theragenics corp., C.R. Bard, Eckert & Ziegler BEBIG SA. |
Upcoming |
|
|
Asian Internal Beam Radiotherapy/Brachytherapy Market The Asian Internal Beam Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $68.2 million in 2013 and expected to be $90.6 million by 2018, growing at a CAGR of 5.8%. The Internal Beam Radiotherapy Market analyzes the market of devices by 3 segments such as Brachytherapy Seeds, Applicators & Afterloaders and Electronic Brachytherapy.The prominent players in the Radiotherapy Devices Market globally areElekta AB, Theragenics corp., C.R. Bard, Eckert & Ziegler BEBIG SA. |
Upcoming |
